Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial
- PMID: 36413569
- DOI: 10.1093/bjs/znac418
Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial
Comment in
-
Author response to: Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.Br J Surg. 2023 Jan 10;110(2):284. doi: 10.1093/bjs/znac420. Br J Surg. 2023. PMID: 36413576 No abstract available.
Comment on
-
Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.Br J Surg. 2023 Jan 10;110(2):150-158. doi: 10.1093/bjs/znac324. Br J Surg. 2023. PMID: 36224406 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
